What is WGS's gross margin?

GeneDx (WGS) has a gross margin of 67% and a net margin of -62%.

What is WGS's P/E ratio?

Track GeneDx (WGS) P/E ratio, ROE, and valuation metrics over time.

Where can I see WGS's full financials?

See GeneDx (WGS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

GeneDx (WGS) Financials — Revenue, Earnings, Cash Flow

Also trades as: WGSWW (NASDAQ) · $vol 0M

$47.31

-0.02 (-0.04%)

Weekly Expected Move ±27.4%

$18 $30 $41 $52 $63

NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Sell · Power 38 · $1.4B mcap · 26M float · 4.48% daily turnover · Short 56% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$443M

Revenue

+34.1% YoY

$-78M

Net Income

-101.7% YoY

$-29M

Free Cash Flow

-119.1% YoY

66.7%

Gross Margin

-25.6%

Op. Margin

-61.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-28.1%

ROA-15.7%

ROIC-9.4%

Valuation

P/E-17.8

P/B5.5

EV/EBITDA-38.4

Leverage

Debt/Equity0.49

Current Ratio2.46

Interest Cov.-28.6x

Quality Scores

Piotroski F3/9

Altman Z1.62

Beneish M-2.19